Proceedings from the National Institute of Child Health and Human Development Conference on the Uterine Fibroid Research Update Workshop

Fertility and Sterility

Volumn 95, Issue 1, 2011, Pages 9-12

  Catherino, William H ^a,b   Parrott, Estella ^a   Segars, James ^a,b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

clinical trials; epidemiology; etiology; Leiomyoma; myometrium; therapy

Indexed keywords

ANTIGESTAGEN; CATECHOL METHYLTRANSFERASE; CYTOCHROME P450 1A1; GANCICLOVIR; GENE PRODUCT; GESTAGEN; HALOFUGINONE; HIGH MOBILITY GROUP A1A PROTEIN; HIGH MOBILITY GROUP A2 PROTEIN; JANUS KINASE 2; LEPTIN; MIFEPRISTONE; RESVERATROL; RETINOIC ACID; STAT3 PROTEIN; THYMIDINE KINASE; ULIPRISTAL;

AFRICAN AMERICAN; CAUCASIAN; CELL CYCLE ARREST; CELL PROLIFERATION; CHILD HEALTH; CHROMATIN IMMUNOPRECIPITATION; CLINICAL RESEARCH; ENDOMETRIUM BIOPSY; EXTRACELLULAR MATRIX; FERTILIZATION IN VITRO; FIBROSIS; GENE EXPRESSION; GENETIC LINKAGE; GENETIC PREDISPOSITION; HUMAN; MENTAL STRESS; MICROARRAY ANALYSIS; NATIONAL HEALTH ORGANIZATION; NONHUMAN; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SPONTANEOUS ABORTION; TREATMENT DURATION; UTERUS MYOMA; VIRUS DETECTION; CLINICAL TRIAL (TOPIC); CONFERENCE PAPER; CONSENSUS DEVELOPMENT; EDUCATION; FEMALE; LEIOMYOMA; PATHOPHYSIOLOGY;

CLINICAL TRIALS AS TOPIC; EDUCATION; FEMALE; HUMANS; LEIOMYOMA;

EID: 78650420556     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2010.08.049     Document Type: Article

References (27)

1. E.C. Feinberg, F.W. Larsen, W.H. Catherino, J. Zhang, and A.Y. Armstrong Comparison of assisted reproductive technology utilization and outcomes between Caucasian and African American patients in an equal-access-to-care setting Fertil Steril 85 2006 888 894
2. J.C. Hodge, K. T Cuenco, K.L. Huyck, P. Somasundaram, C.I. Panhuysen, and E.A. Stewart Uterine leiomyomata and decreased height: a common HMGA2 predisposition allele Hum Genet 125 2009 257 263
3. A. Al-Hendy, and S.A. Salama Catechol-O-methyltransferase polymorphism is associated with increased uterine leiomyoma risk in different ethnic groups J Soc Gynecol Investig 13 2006 136 144
4. S.K. Laughlin, D.D. Baird, D.A. Savitz, A.H. Herring, and K.E. Hartmann Prevalence of uterine leiomyomas in the first trimester of pregnancy: an ultrasound-screening study Obstet Gynecol 113 2009 630 635
5. W.H. Catherino, M. Malik, P. Driggers, S. Chappel, J. Segars, and J. Davis Novel, orally active selective progesterone receptor modulator CP8947 inhibits leiomyoma cell proliferation without adversely affecting endometrium or myometrium J Steroid Biochem Mol Biol 122 2010 279 286
6. M. Malik, J. Norian, D. McCarthy-Keith, J. Britten, and W.H. Catherino Why leiomyomas are called fibroids: the central role of extracellular matrix in symptomatic women Semin Reprod Med 28 2010 169 179
7. J.M. Norian, M. Malik, C.Y. Parker, D. Joseph, P.C. Leppert, and J.H. Segars Transforming growth factor beta3 regulates the versican variants in the extracellular matrix-rich uterine leiomyomas Reprod Sci 16 2009 1153 1164
8. D.S. Joseph, M. Malik, S. Nurudeen, and W.H. Catherino Myometrial cells undergo fibrotic transformation under the influence of transforming growth factor beta-3 Fertil Steril 93 2010 1500 1508
9. M. Malik, M. Mendoza, M. Payson, and W.H. Catherino Curcumin, a nutritional supplement with antineoplastic activity, enhances leiomyoma cell apoptosis and decreases fibronectin expression Fertil Steril 91 2009 2177 2184
10. M. Malik, J. Webb, and W.H. Catherino Retinoic acid treatment of human leiomyoma cells transformed the cell phenotype to one strongly resembling myometrial cells Clin Endocrinol (Oxf) 69 2008 462 470
11. H.R. Mason, A.C. Lake, J.E. Wubben, R.A. Nowak, and J.J. Castellot Jr. The growth arrest-specific gene CCN5 is deficient in human leiomyomas and inhibits the proliferation and motility of cultured human uterine smooth muscle cells Mol Hum Reprod 10 2004 181 187
12. P. Yin, Z. Lin, S. Reierstad, J. Wu, H. Ishikawa, and E.E. Marsh Transcription factor KLF11 integrates progesterone receptor signaling and proliferation in uterine leiomyoma cells Cancer Res 70 2010 1722 1730
13. H. Ishikawa, S. Reierstad, M. Demura, A.W. Rademaker, T. Kasai, and M. Inoue High aromatase expression in uterine leiomyoma tissues of African-American women J Clin Endocrinol Metab 94 2009 1752 1756
14. F.S. Mesquita, S.N. Dyer, D.A. Heinrich, S.E. Bulun, E.E. Marsh, and R.A. Nowak Reactive oxygen species mediate mitogenic growth factor signaling pathways in human leiomyoma smooth muscle cells Biol Reprod 82 2010 341 351
15. A.V. Hoekstra, E.C. Sefton, E. Berry, Z. Lu, J. Hardt, and E. Marsh Progestins activate the AKT pathway in leiomyoma cells and promote survival J Clin Endocrinol Metab 94 2009 1768 1774
16. R. Rogers, J. Norian, M. Malik, G. Christman, M. Abu-Asab, and F. Chen Mechanical homeostasis is altered in uterine leiomyoma Am J Obstet Gynecol 198 2008 474.e1-11
17. M.M. Grudzien, P.S. Low, P.C. Manning, M. Arredondo, R.J. Belton Jr., and R.A. Nowak The antifibrotic drug halofuginone inhibits proliferation and collagen production by human leiomyoma and myometrial smooth muscle cells Fertil Steril 93 2010 1290 1298
18. X. Luo, P. Yin, S. Reierstad, H. Ishikawa, Z. Lin, and M.E. Pavone Progesterone and mifepristone regulate L-type amino acid transporter 2 and 4F2 heavy chain expression in uterine leiomyoma cells J Clin Endocrinol Metab 94 2009 4533 4539
19. Q. Pan, X. Luo, and N. Chegini Differential expression of microRNAs in myometrium and leiomyomas and regulation by ovarian steroids J Cell Mol Med 12 2008 227 240
20. Q. Pan, X. Luo, and N. Chegini microRNA 21: response to hormonal therapies and regulatory function in leiomyoma, transformed leiomyoma and leiomyosarcoma cells Mol Hum Reprod 16 2010 215 227
21. J.D. Short, K.D. Houston, R. Dere, S.L. Cai, J. Kim, and C.L. Johnson AMP-activated protein kinase signaling results in cytoplasmic sequestration of p27 Cancer Res 68 2008 6496 6506
22. I.K. Dimitrova, J.K. Richer, M.C. Rudolph, N.S. Spoelstra, E.M. Reno, and T.M. Medina Gene expression profiling of multiple leiomyomata uteri and matched normal tissue from a single patient Fertil Steril 91 2009 2650 2663
23. S.H. Eisinger, J. Fiscella, T. Bonfiglio, S. Meldrum, and K. Fiscella Open-label study of ultra low-dose mifepristone for the treatment of uterine leiomyomata Eur J Obstet Gynecol Reprod Biol 146 2009 215 218
24. E.D. Levens, C. Potlog-Nahari, A.Y. Armstrong, R. Wesley, A. Premkumar, and D.L. Blithe CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial Obstet Gynecol 111 2008 1129 1136
25. M.H. Hassan, S.A. Salama, D. Zhang, H.M. Arafa, F.M. Hamada, and H. Fouad Gene therapy targeting leiomyoma: adenovirus-mediated delivery of dominant-negative estrogen receptor gene shrinks uterine tumors in Eker rat model Fertil Steril 93 2010 239 250
26. M. Hassan, D. Zhang, S. Salama, F. Hamada, H. Arafa, and H. Fouad Towards fibroid gene therapy: adenovirus-mediated delivery of herpes simplex virus 1 thymidine kinase gene/ganciclovir shrinks uterine leiomyoma in the Eker rat model Gynecol Obstet Invest 68 2009 19 32
27. D. McCarthy-Keith, S. Nurudeen, A. Armstrong, E. Levens, and L.K. Nieman Recruitment and retention of women for clinical leiomyoma trials Contemp Clin Trials 31 2010 44 48